相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET ONCOLOGY (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma
Savita Bhalla et al.
BLOOD (2011)
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade
Michael K. Kiessling et al.
BLOOD (2011)
Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2
Xin-Yan Pei et al.
BLOOD (2011)
GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition
Aidan G. Gilmartin et al.
CLINICAL CANCER RESEARCH (2011)
Integrated T-cell receptor and costimulatory signals determine TGF-β-dependent differentiation and maintenance of Foxp3+ regulatory T cells
Leona Gabrysova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Blockade of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase and Murine Double Minute Synergistically Induces Apoptosis in Acute Myeloid Leukemia via BH3-Only Proteins Puma and Bim
Weiguo Zhang et al.
CANCER RESEARCH (2010)
Central Memory CD8+ T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia
Hong Zheng et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Late Memory CD8+ T Cells Have a Distinct Cytokine Signature Characterized by CC Chemokine Production without IL-2 Production
Tae Kon Kim et al.
JOURNAL OF IMMUNOLOGY (2009)
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
Sydney X. Lu et al.
BLOOD (2008)
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers
Alex A. Adjei et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cutting edge:: TGF-β-induced expression of Foxp3 in T cells is mediated through inactivation of ERK
Xunrong Luo et al.
JOURNAL OF IMMUNOLOGY (2008)
Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease
Hong Zheng et al.
BLOOD (2008)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses
Melissa L. Precopio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse
Benny J. Chen et al.
BLOOD (2007)
Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor
Tammie C. Yeh et al.
CLINICAL CANCER RESEARCH (2007)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Pathophysiology of graft-versus-host disease
JLM Ferrara et al.
SEMINARS IN HEMATOLOGY (2006)
Host-reactive CD8+ memory stem cells in graft-versus-host disease
Y Zhang et al.
NATURE MEDICINE (2005)
Transfer of aflogeneic CD62L- memory T cells without graft-versus-host disease
BJ Chen et al.
BLOOD (2004)
Functional assessment and specific depletion of alloreactive human T cells using flow cytometry
SLR Martins et al.
BLOOD (2004)
Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management
D Couriel et al.
CANCER (2004)
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies
M Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Memory CD4+ T cells do not induce graft-versus-host disease
BE Anderson et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
TCR signal transduction in antigen-specific memory CD8 T cells
EN Kersh et al.
JOURNAL OF IMMUNOLOGY (2003)
Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells
E Özdemir et al.
BLOOD (2002)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers
LE Gamadia et al.
BLOOD (2001)
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis
KV Komanduri et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Skewed maturation of memory HIV-specific CD8 T lymphocytes
P Champagne et al.
NATURE (2001)
分享论文
